* This Webinar is not part of Unofficial Satellite Events of AHA 2015.

Slides:



Advertisements
Similar presentations
Satellite Symposium at the American Heart Association Meeting 2013 Sunday, Nov. 17, 2013 Robert A. Kloner, MD, PhD Professor of Medicine Keck School of.
Advertisements

Presented by: Fahim H. Jafary, M.D., F.A.C.C. Associate Professor of Medicine Aga Khan University Hospital, Karachi March 14, 2008 Primary Percutaneous.
Update on Anti-platelets Gabriel A. Vidal, MD Vascular Neurology Ochsner Medical Center October 14 th, 2009.
Introduction Recent guidelines considered PCI to be a potential alternative to CABG for ULMCA stenosis, based on several large registries and randomized.
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
Clinical Trial Results. org Tilman B. Drüeke, M.D.; Francesco Locatelli, M.D.; Naomi Clyne, M.D.; Kai-Uwe Eckardt, M.D.; Iain C. Macdougall, M.D.; Dimitrios.
Update on the Medical Management of Acute Coronary Syndrome.
David Liebeskind (UCLA) Imaging
The INSIGHT study - Reliable blood pressure control and additional benefits for hypertensive patients Anthony M Heagerty Department of Medicine Manchester.
Can we prevent stent restenosis after coronary stent implantation
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin.
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
0902CZR01NL537SS0901 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist.
Ischemic heart disease Basic Science 3/15/06. All of the following concerning coronary artery anatomy are correct except: The left main coronary artery.
BARI 2D Trial BARI 2D Trial Presented at the American Diabetes Association (ADA) Annual Scientific Sessions 2009 in New Orleans The Bypass Angioplasty.
Enhancement of thrombolysis in AMI is an unmet clinical need Increase the rate of reperfusion without increasing bleeding Reduce the time to complete reperfusion.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Remote Ischemic Conditioning: An Update on Mechanisms Remote Ischemic Conditioning: An Update on Mechanisms Karin Przyklenk PhD Director, Cardiovascular.
Minimise the damage – Pre- and Post-conditioning Dr Derek J Hausenloy The Hatter Cardiovascular Institute, University College London, UK. Myocardial Recovery.
Aspirin Resistance: Significance, Detection and Clinical Management of This Real Phenomenon Webcast May 10 th, 2004 Sponsored by.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.
OVERALL SURVIVAL Adapted from Scandinavian Simvastatin Survival Study Group Lancet 1994;344: % of patients alive Simvastatin (n=2221)
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
S Reducion of infarction size as a target Mohamed Mahmoud Abd El Ghany Mohamed Mahmoud Abd El Ghany Cardiology Professor of Cairo University.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
4S: Scandinavian Simvastatin Survival Study
Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Can we better protect patients who undergo revascularization? Beneficial effects of short- and long-term trimetazidine MR therapy in patients undergoing.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
IABP用于高危PCI有价值吗? Is IABP Valuable for High-Risk PCI?
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
Can we improve the management of angina patients after percutaneous coronary intervention? Beneficial effects of adding trimetazidine MR therapy after.
Annual Patient Admissions for Acute Coronary Syndromes 1.4 MM Non-ST elevation ACS 0.6 MM ST-elevation MI ~ 2.0 MM patients admitted to CCU or telemetry.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization.
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.
Total Occlusion Study of Canada (TOSCA-2) Trial
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
CRT 2015 Unmet Needs in STEMI Interventions
Revascularization in Patients With Left Ventricular Dysfunction:
Clinical need for determination of vulnerable plaques
Previous Relative Trials
A Webinar Presentation on December 8th, PM PST
Time Is Myocardium and the Wavefront of Necrosis
Preventive Angioplasty in Myocardial Infarction Trial
American College of Cardiology Presented by Dr. Michel R. Le May
Association of Troponin Elevation with Risk of Mortality in Acute Coronary Syndromes Mortality at 42 Days  % A study by Antman and.
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

* This Webinar is not part of Unofficial Satellite Events of AHA 2015

UPDATE ON Cardiac Protection and Clinical Trials on Remote Ischemic Preconditioning Robert A. Kloner MD, PhD Director of the Cardiovascular Research Institute of HMRI VP of Translation, HMRI Professor of Clinical Medicine, Division of Cardiovascular Medicine, Dept. of Medicine, Keck School of Medicine at University of Southern California Conflict of interest: Dr. Kloner has been a speaker for Gilead, IC Therapeutics, and Lilly

Myocardial Infarction (Heart Attack) In the US there are close to 1 million myocardial infarctions (MI) annually. Despite improved survival rates with early reperfusion therapy (thrombolytics, angioplasty, stenting), there is still a 1 month mortality rate of ~10% and a one year mortality rate of ~13%. Congestive heart failure remains a significant morbidity (~25% in 1yr post-MI).

A recent study in the NEJM showed that although the time from ambulance arrival to reopening the occluded artery in a catheterization laboratory has shortened in the US (~90 min), further shortening of time has not improved mortality (1). Better interventions are needed. Heart attack size correlates with mortality and heart failure. Even a 5% reduction in size improves clinical outcome (2,3). 1.Menees DS et al. NEJM 2013;369: Boden H et al. Am J Cardiol 2013;111: Turer AT et al. Curr Control Trials Cardiovasc Med Aug 23;6:12.

Clinical Trials of MI Reduction Many pharmacologic agents that were cardioprotective in animal models failed in clinical trials.

PZ Gerczuk and RA Kloner JACC 2012;59:

The Preconditioning Phenomenon The heart’s own self-preserving mechanism Brief periods of ischemia (2-5 minutes) prior to a longer duration of ischemia:  Reduce infarct size in most models  Reduce ventricular arrhythmias If we can learn the mechanism of preconditioning, it may lead to potentially important therapies.

40 min occlusion plus 4 hours reperfusion in anesthetized rabbit; Left = control; Right = preconditioned with two 5 min occlusions plus 5 min reperfusion before the long occlusion. Hale SL, Kloner RA Coronary Artery Disease 1992;3:

Effects of preconditioning on myocardial infarct size in dogs Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation Nov;74(5):

Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation Nov;74(5):

Clinical Evidence For Preconditioning Less chest pain, ST-segment elevation, lactate production with subsequent compared to first angioplasty balloon inflation Reduction in infarct size, mortality and CHF in patients with history of angina before acute MI Acute tolerance to angina (warm up phenomenon) Studies performed on human cardiac tissue: ▫ATP levels during CABG ▫In vitro studies on isolated human muscle ▫In vitro studies on human myocytes

Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson M, Poole WK, Cannon CP, McCabe C, Braunwald E, for the TIMI 4 Investigators. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995; 91:37-45.

Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson M, Poole WK, Cannon CP, McCabe C, Braunwald E, for the TIMI 4 Investigators. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995; 91:37-45.

Remote Ischemic Preconditioning or Ischemic Conditioning at a Distance Ischemic conditioning of one vascular bed may protect a remote vascular bed. This could occur within the same organ or between different organs.

Mechanisms StimulusEffectorCell- signaling Protection 4 cycles of 5 min. I 5 min. R Ischemic tissue releases “drug cocktail”

Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion In this study, preconditioning the circumflex coronary artery bed reduced infarct size when the left anterior descending artery was occluded for 60 min followed by reperfusion. Showed that “Brief episodes of ischemia in one vascular bed protect remote, virgin myocardium from subsequent sustained coronary artery occlusion in canine model.” Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation Mar;87(3):893-9

Regional ischemic preconditioning protects remote virgin myocardium Przyklenk K. et al. Circulation 1993;87:893

Ischemic preconditioning at a distance. Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in rabbit. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation Sep 2;96(5): Showed that remote ischemia of a skeletal muscle could precondition the myocardium.

R emote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial 333 patients with first AMI randomized to primary PCI with or without remote conditioning (4 cycles of 5-minute brachial artery cuff inflation & 5 minutes deflation) Median salvage index by myocardial perfusion imaging 0.75 in remote conditioning group versus 0.55 in control group, p = 0.03 Conclusion: Remote ischemic conditioning before hospital admission increases myocardial salvage and is safe. Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sørensen HT, Redington AN, Nielsen TT. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet Feb 27;375(9716):727.

Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention (The CONDI Study) 333 pts with a first acute ST-elevation myocardial infarction were randomized to primary percutaneous coronary intervention with (n = 166) or without (n = 167) remote ischemic conditioning (intermittent arm ischemia through four cycles of 5-min inflation followed by 5-min deflation of a blood-pressure cuff The primary endpoint was major adverse cardiac and cerebrovascular events (MACCE)—a composite of all-cause mortality, myocardial infarction, readmission for heart failure, and ischemic stroke/transient ischemic attack. Hazard ratio for the primary composite endpoint and for the secondary endpoints in the follow- up period (median follow-up 3.8 yrs). Sloth AD, et al,European Heart Journal (2014) 35, 168–175

70 RIPC studies listed at ClinicalTrials.gov – accessed on 10/29/15. RankStatusStudy 1Not yet recruitingEffect of Remote Ischaemic Conditioning in Oncology Patients Condition:Cardiotoxicity Number Enrolled:128 2RecruitingRemote Ischemic Pre-conditioning in Subarachnoid Hemorrhage Condition:Brain Aneurysms Number Enrolled:100 3RecruitingEffects of Remote Ischemic PreConditioning in Off-pump Versus On-pump Coronary Artery Bypass Grafting(RIPCON) Condition:Myocardial Injury Number Enrolled:100 4RecruitingInterest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy in High Risk Patients Condition:Nephropathy Number Enrolled:100 5RecruitingRemote Ischemic Conditioning in ST-elevation Myocardial Infarction as Adjuvant to Primary Angioplasty Condition:ST Elevation Myocardial Infarction Number Enrolled:492 Search link

Source: Location of 70 RIPC studies listed at ClinicalTrials.gov – accessed on 10/29/15.

CABG Sharma et al., Cardiovasc Drugs Ther, 2015

Non-emergent PCI Sharma et al., Cardiovasc Drugs Ther, 2015

(continued) PCI Sharma et al., Cardiovasc Drugs Ther, 2015

Meta-analysis of RIPC Cardioprotection Enzymes Le Page et al., Basic Res Cardiol, 2015

Meta-analysis of RIPC Cardioprotection Outcomes Le Page et al., Basic Res Cardiol, 2015

Mybohm P et al NEJM 2015; 373:

DJ Hausenloy N Engl J Med 2015; 373:

Ischemic Conditioning-Potential Applications Reducing myocardial infarct size Reducing cardiac damage during percutaneous coronary intervention Protecting the myocardium during coronary artery bypass grafting and other procedures requiring cardiopulmonary bypass Protecting the vasculature during vascular surgery procedures Unstable angina Before activities that reproducibly cause angina in patients with stable angina Protecting donor hearts before excision and transport Protecting other organs (brain, kidney) during episodes of ischemia

Neurogenic pathway mediated remote preconditioning protects the brain from transient focal ischemic injury. Malhotra S, et al. Brain Res. 2011;1386: Adult Wistar male rats underwent remote preconditioning (RIPC) or sham surgery Then 2 hours middle cerebral artery occlusion (MCO) Those having MCO 24 hours after RIPC had significantly smaller cerebral infarct volumes (150 mm3) versus controls (250 mm3; p<0.05) and better neurological scores Ganglion blocker (hexamethonium) blocked the benefit

Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Meng R, et al. Neurology. 2012;79(18): cases symptomatic atherosclerotic arterial stenosis (diagnosed by imaging) Bilateral arm ischemic preconditioning (BAIPC, n=38) underwent 5 brief bilateral upper limb ischemia followed by reperfusion Twice a day over 300 days Incidence of recurrent stroke at 90 and 300 days were 23% and 26% respectively in untreated control group versus 5% and 7.9% respectively in preconditioning group (p < 0.01) SPECT measure of cerebral flow improved in preconditioning group

Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment. Meng R, et al. Neurotherapeutics. 2015;12(3): Effectiveness of bilateral arm ischemic preconditioning (BAIPC) in reducing stroke recurrence in in octo- and nonagenarians patients 58 patients with symptomatic intracranial arterial stenosis randomized to BAIPC (5 cycles twice daily) versus sham for 180 days BAIPC reduced hsCRP, IL-6, IL-1 and leukocyte count At 180 days 2 infarctions and 7 TIAs in BAIPC group versus 8 infarctions and 11 TIAs in sham group (p < 0.05)

Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Hougaard KD, et al. Stroke. 2014;45(1): patients suspected acute stroke Alteplase MRI 24 hours, 1 months Primary end point: penumbral salvage, volume of the perfusion- diffusion mismatch not progressing to infarction after 1 month After adjustment for baseline perfusion and diffusion lesion severity, voxelwise analysis showed that remote conditioning reduced tissue risk of infarction (P=0.0003)

Ref: Dr. Raymond MacAllister

RenalRIPC Investigators JAMA June 2, 2015, Vol 313, No. 21JAMA June 2, 2015, Vol 313, No. 21

RenalRIPC Investigators

Acute Kidney Injury Zarbock and Kellum, Crit Care Med, 2015

Remote ischemic postconditioning: Harnessing endogenous protection in a murine model of vascular cognitive impairment. Khan MB, Hoda MN, Vaibhav K, et al. Transl Stroke Res 2015; 6: This group previously reported that remote ischemic conditioning during acute stroke confers neuroprotection (Hess DC et al. Stroke, 2013; 44: ) and increased cerebral blood flow (CBF). They tested whether remote conditioning could augment CBF and prevent cognitive impairment in the BCAS (bilateral common carotid artery stenosis) mouse model. BCAS was induced with customized micro coils in male mice to establish chronic cerebral hypoperfusion, which creates a model of vascular cognitive impairment.

One week after BCAS surgery mice treated with remote ischemic postconditioning once daily for 2 weeks. Cognitive testing performed at 4 weeks. RESULTS: Remote ischemic postconditioning improved cognitive function, inhibited inflammatory responses and prevented cell death, decreased accumulation of amyloid beta protein and protected white matter integrity.

Khan MB, Hoda MN, Vaibhav K, et al. Transl Stroke Res 2015; 6: 69-77

Summary " Remote ischemic postconditioning is effective in the bilateral common carotid artery stenosis model and could be an attractive low-cost conventional therapy for aged individuals with vascular cognitive impairment. The mechanism by which RIPostC improves cerebral blood flow and attenuates tissue damage needs to be investigated in the future."

Basic Res Cardiol (2015) 110:453

Athletic Performance Sharma et al., Cardiovasc Drugs Ther, 2015